Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Jun 16 2022

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · · 3 pages · English and French

Release

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 16-Jun-2022 titled Glenmark becomes the First Pharmaceutical Company to launch Indacaterol + Mometasone Fixed-Dose Combination Drug for Asthma in India

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases